Preferred Label : mexiletine;

MeSH definition : Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.;

CISMeF synonym : boehringer ingelheim brand of mexiletine hydrochloride; novopharm brand of mexiletine hydrochloride;

MeSH hyponym : mexitil; mexiletene; Novo-Mexiletine; KO-1173; mexiletine hydrochloride; Novo Mexiletine; Mexitil PL; Mexityl; KO 1173; KO1173; KOE-1173; KOE 1173; KOE1173;

MeSH CAS label : 2-Propanamine, 1-(2,6-dimethylphenoxy)-;

MeSH Related Number : mexiletine hydrochloride; 31828-71-4 (Mexiletine); 5370-01-4 (Mexiletine hydrochloride); 606D60IS38;

Registry Number MeSH : 31828-71-4;

Related CAS MeSH : 606D60IS38 (Mexiletine hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Mexiletine;

Codes EINECS : 250-825-7;

Is substance : O;

UNII : 1U511HHV4Z;

InChIKey : VLPIATFUUWWMKC-UHFFFAOYSA-N;

Details


Main resources

You can consult :

Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.

https://ansm.sante.fr/tableau-acces-derogatoire/namuscla-167-mg-gelule
2024
false
false
false
France
French
drug information
mexiletine
guidelines for drug use
adult
myotonic dystrophy

---
https://ansm.sante.fr/tableau-marr/chlorhydrate-de-mexiletine
2023
false
false
false
France
French
pharmacovigilance note
mexiletine hydrochloride
guidelines for drug use
risk management
mexiletine hydrochloride
arrhythmias, cardiac
hepatic insufficiency
mexiletine hydrochloride
patient education handout
Drug-Related side effects and adverse reactions
risk
continuity of patient care
mexiletine
mexiletine
mexiletine

---
https://www.has-sante.fr/jcms/p_3246176/fr/namuscla
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
mexiletine
administration, oral
adult
Voltage-Gated sodium channel blockers
myotonic dystrophy
continuity of patient care
drug monitoring
drug evaluation
guidelines for drug use

---
https://www.ema.europa.eu/en/medicines/human/EPAR/namuscla
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
mexiletine
mexiletine
orphan drug production
myotonia
nondystrophic myotonia
administration, oral
Voltage-Gated sodium channel blockers
Voltage-Gated sodium channel blockers
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3135571/fr/namuscla
2019
false
false
false
France
French
administration, oral
insurance, health, reimbursement
treatment outcome
mexiletine
adult
evaluation of the transparency committee
nondystrophic myotonia
myotonia

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/mexiletine_-_ct-9407.pdf
http://www.has-sante.fr/portail/jcms/c_1050983/mexiletine-ap-hp-mexiletine-agent-bloquant-du-canal-sodique
2011
France
French
evaluation of the transparency committee
guidelines for drug use
mexiletine
other drugs for disorders of the musculo-skeletal system
administration, oral
myotonic disorders
adult
treatment outcome
mexiletine
myotonia
Myotonic syndrome

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/mexiletine_-_ct-9407.pdf
http://www.has-sante.fr/portail/jcms/c_1024114/mexiletine
2011
France
French
mexiletine
administration, oral
other drugs for disorders of the musculo-skeletal system
myotonic disorders
adult
treatment outcome
mexiletine
evaluation of the transparency committee
comparative study

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68999853
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=68999853&typedoc=R&ref=R0179688.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=68999853&typedoc=N&ref=N0179688.htm
2010
France
French
Contraindications, Procedure
capsules
mexiletine
other drugs for disorders of the musculo-skeletal system
mexiletine
continuity of patient care
administration, oral
myotonic disorders
mexiletine
mexiletine
drug interactions
pregnancy
adult
summary of product characteristics
package leaflet
Contraindications, Drug

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.